APA (7th ed.) Citation

M, H., T, H., M, E., H, S., S, B., C, S., . . . D, H. (2024). Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation. JCO precision oncology, 8, e2300613. https://doi.org/10.1200/PO.23.00613

Chicago Style (17th ed.) Citation

M, Hummel, et al. "Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation." JCO Precision Oncology 8 (2024): e2300613. https://doi.org/10.1200/PO.23.00613.

MLA (9th ed.) Citation

M, Hummel, et al. "Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation." JCO Precision Oncology, vol. 8, 2024, p. e2300613, https://doi.org/10.1200/PO.23.00613.